 David Guertin
Concepts (234)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiprotein Complexes | 10 | 2016 | 111 | 2.340 |
Why?
| | Protein Kinases | 10 | 2009 | 138 | 2.280 |
Why?
| | Adipogenesis | 6 | 2018 | 45 | 2.090 |
Why?
| | Proto-Oncogene Proteins c-akt | 10 | 2020 | 146 | 2.020 |
Why?
| | Adipocytes, Brown | 3 | 2020 | 11 | 1.790 |
Why?
| | Carrier Proteins | 8 | 2020 | 617 | 1.590 |
Why?
| | Myogenic Regulatory Factor 5 | 4 | 2014 | 16 | 1.540 |
Why?
| | Adipose Tissue, White | 4 | 2016 | 32 | 1.530 |
Why?
| | Adipocytes | 4 | 2016 | 165 | 1.440 |
Why?
| | Signal Transduction | 19 | 2016 | 2280 | 1.430 |
Why?
| | Transcription Factors | 9 | 2016 | 1212 | 1.370 |
Why?
| | Adipocytes, White | 2 | 2015 | 10 | 1.260 |
Why?
| | PTEN Phosphohydrolase | 4 | 2012 | 66 | 1.250 |
Why?
| | Neoplasms | 4 | 2012 | 604 | 1.180 |
Why?
| | Obesity | 3 | 2016 | 881 | 1.160 |
Why?
| | Lipogenesis | 2 | 2020 | 22 | 1.120 |
Why?
| | ATP Citrate (pro-S)-Lyase | 1 | 2020 | 2 | 0.970 |
Why?
| | Protein Kinase Inhibitors | 2 | 2012 | 75 | 0.970 |
Why?
| | Cell Lineage | 5 | 2014 | 199 | 0.960 |
Why?
| | Cell Growth Processes | 2 | 2012 | 37 | 0.960 |
Why?
| | Cell Division | 5 | 2006 | 436 | 0.920 |
Why?
| | Animals | 29 | 2020 | 14891 | 0.890 |
Why?
| | Gastrointestinal Transit | 1 | 2018 | 4 | 0.870 |
Why?
| | Sirolimus | 6 | 2012 | 62 | 0.830 |
Why?
| | Prostatic Neoplasms | 2 | 2012 | 237 | 0.810 |
Why?
| | Trans-Activators | 2 | 2012 | 284 | 0.790 |
Why?
| | Mice | 17 | 2020 | 7520 | 0.780 |
Why?
| | Adipose Tissue, Brown | 2 | 2014 | 28 | 0.760 |
Why?
| | Protein-Serine-Threonine Kinases | 6 | 2010 | 325 | 0.730 |
Why?
| | Cell Cycle Proteins | 4 | 2004 | 287 | 0.730 |
Why?
| | Liver | 3 | 2016 | 545 | 0.700 |
Why?
| | Protein Subunits | 1 | 2016 | 148 | 0.700 |
Why?
| | Integrases | 1 | 2015 | 23 | 0.690 |
Why?
| | Subcutaneous Fat | 1 | 2015 | 22 | 0.680 |
Why?
| | rab1 GTP-Binding Proteins | 1 | 2014 | 6 | 0.680 |
Why?
| | Homeodomain Proteins | 1 | 2015 | 197 | 0.600 |
Why?
| | Nuclear Proteins | 2 | 2016 | 693 | 0.590 |
Why?
| | Colorectal Neoplasms | 1 | 2014 | 145 | 0.590 |
Why?
| | Schizosaccharomyces pombe Proteins | 3 | 2004 | 61 | 0.580 |
Why?
| | Schizosaccharomyces | 4 | 2004 | 85 | 0.570 |
Why?
| | Energy Metabolism | 1 | 2014 | 264 | 0.550 |
Why?
| | Gene Knockout Techniques | 1 | 2012 | 39 | 0.540 |
Why?
| | Drosophila Proteins | 5 | 2011 | 629 | 0.530 |
Why?
| | Cell Differentiation | 3 | 2013 | 1053 | 0.520 |
Why?
| | Autophagy | 1 | 2012 | 122 | 0.520 |
Why?
| | Cell Survival | 1 | 2012 | 436 | 0.510 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2001 | 60 | 0.490 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 1 | 2009 | 35 | 0.440 |
Why?
| | Proteins | 9 | 2012 | 593 | 0.440 |
Why?
| | Antibiotics, Antineoplastic | 2 | 2006 | 27 | 0.440 |
Why?
| | Saccharomyces cerevisiae Proteins | 3 | 2004 | 375 | 0.440 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2010 | 219 | 0.420 |
Why?
| | Protein Kinase C-alpha | 2 | 2006 | 15 | 0.410 |
Why?
| | Forkhead Transcription Factors | 2 | 2011 | 81 | 0.410 |
Why?
| | Phosphorylation | 7 | 2020 | 664 | 0.390 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2006 | 5 | 0.390 |
Why?
| | Genes, Developmental | 1 | 2006 | 5 | 0.380 |
Why?
| | Drosophila | 3 | 2006 | 384 | 0.370 |
Why?
| | Mice, Inbred C57BL | 5 | 2020 | 2312 | 0.350 |
Why?
| | Gene Expression | 2 | 2020 | 613 | 0.340 |
Why?
| | Humans | 16 | 2020 | 33683 | 0.330 |
Why?
| | Mice, Knockout | 4 | 2016 | 1626 | 0.320 |
Why?
| | Thermogenesis | 2 | 2014 | 8 | 0.320 |
Why?
| | Mitosis | 2 | 2002 | 193 | 0.310 |
Why?
| | Body Fat Distribution | 2 | 2013 | 11 | 0.300 |
Why?
| | Genes, cdc | 1 | 2002 | 10 | 0.290 |
Why?
| | RNA Interference | 6 | 2011 | 510 | 0.280 |
Why?
| | PPAR gamma | 2 | 2020 | 59 | 0.270 |
Why?
| | Male | 9 | 2016 | 17020 | 0.270 |
Why?
| | Protein Binding | 5 | 2009 | 1224 | 0.270 |
Why?
| | Luminescent Proteins | 3 | 2012 | 124 | 0.260 |
Why?
| | Cells, Cultured | 5 | 2014 | 1821 | 0.260 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2012 | 176 | 0.260 |
Why?
| | Gene Targeting | 2 | 2015 | 79 | 0.260 |
Why?
| | Insulin Resistance | 2 | 2016 | 311 | 0.260 |
Why?
| | Gene Expression Profiling | 4 | 2011 | 482 | 0.250 |
Why?
| | Acetate-CoA Ligase | 1 | 2020 | 1 | 0.240 |
Why?
| | Muscle, Skeletal | 3 | 2014 | 480 | 0.240 |
Why?
| | Response Elements | 1 | 2020 | 31 | 0.240 |
Why?
| | Glucose Transporter Type 4 | 1 | 2020 | 56 | 0.240 |
Why?
| | Gene Expression Regulation | 3 | 2016 | 1257 | 0.230 |
Why?
| | Proteomics | 1 | 2020 | 123 | 0.220 |
Why?
| | Models, Biological | 4 | 2009 | 976 | 0.220 |
Why?
| | Glucose | 3 | 2016 | 306 | 0.220 |
Why?
| | Female | 6 | 2016 | 18527 | 0.220 |
Why?
| | Tumor Suppressor Proteins | 2 | 2012 | 162 | 0.220 |
Why?
| | Stromal Cells | 1 | 2018 | 49 | 0.210 |
Why?
| | Gene Deletion | 2 | 2016 | 239 | 0.200 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 195 | 0.200 |
Why?
| | Adaptor Proteins, Signal Transducing | 4 | 2013 | 288 | 0.200 |
Why?
| | Mutation | 4 | 2006 | 1743 | 0.200 |
Why?
| | Histones | 1 | 2020 | 351 | 0.190 |
Why?
| | Flow Cytometry | 2 | 2012 | 616 | 0.180 |
Why?
| | Protein Structure, Tertiary | 4 | 2015 | 689 | 0.170 |
Why?
| | Cytoskeleton | 2 | 2006 | 123 | 0.170 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 2 | 2011 | 15 | 0.170 |
Why?
| | Up-Regulation | 2 | 2006 | 322 | 0.160 |
Why?
| | Bone Morphogenetic Protein 7 | 1 | 2014 | 10 | 0.160 |
Why?
| | MyoD Protein | 1 | 2014 | 36 | 0.160 |
Why?
| | Cell Proliferation | 3 | 2013 | 658 | 0.160 |
Why?
| | Receptor, Insulin | 1 | 2014 | 34 | 0.160 |
Why?
| | Lipid Metabolism | 2 | 2011 | 135 | 0.150 |
Why?
| | Th2 Cells | 1 | 2013 | 131 | 0.150 |
Why?
| | Proto-Oncogene Proteins | 2 | 2005 | 274 | 0.150 |
Why?
| | Receptors, Adrenergic, beta-3 | 1 | 2012 | 2 | 0.150 |
Why?
| | Lipomatosis | 1 | 2012 | 6 | 0.150 |
Why?
| | Histological Techniques | 1 | 2012 | 18 | 0.140 |
Why?
| | Leukemia | 1 | 2012 | 45 | 0.140 |
Why?
| | Hematopoiesis | 1 | 2012 | 104 | 0.140 |
Why?
| | Muscle Cells | 1 | 2011 | 15 | 0.140 |
Why?
| | Receptors, Cell Surface | 1 | 2015 | 443 | 0.140 |
Why?
| | Sarcoma | 1 | 2011 | 25 | 0.140 |
Why?
| | Mice, Transgenic | 1 | 2015 | 960 | 0.140 |
Why?
| | Drug Discovery | 1 | 2012 | 23 | 0.140 |
Why?
| | Sterol Regulatory Element Binding Protein 2 | 1 | 2011 | 3 | 0.140 |
Why?
| | Longevity | 1 | 2012 | 59 | 0.130 |
Why?
| | Cell Separation | 1 | 2011 | 134 | 0.130 |
Why?
| | Ribosomal Protein S6 | 1 | 2011 | 1 | 0.130 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 536 | 0.130 |
Why?
| | Lymphocyte Activation | 1 | 2013 | 694 | 0.120 |
Why?
| | Insulin | 3 | 2012 | 566 | 0.120 |
Why?
| | Adenosine Triphosphate | 1 | 2012 | 246 | 0.120 |
Why?
| | Disease Models, Animal | 2 | 2012 | 1202 | 0.120 |
Why?
| | Tacrolimus Binding Protein 1A | 1 | 2009 | 1 | 0.120 |
Why?
| | Microarray Analysis | 2 | 2011 | 48 | 0.110 |
Why?
| | Cell Line | 3 | 2015 | 1755 | 0.110 |
Why?
| | Green Fluorescent Proteins | 2 | 2001 | 303 | 0.110 |
Why?
| | Phenotype | 2 | 2009 | 783 | 0.110 |
Why?
| | Prostate | 1 | 2009 | 42 | 0.110 |
Why?
| | T-Lymphocytes | 1 | 2013 | 898 | 0.110 |
Why?
| | Neoplasm Transplantation | 1 | 2009 | 147 | 0.110 |
Why?
| | Recombinant Proteins | 1 | 2011 | 626 | 0.110 |
Why?
| | Fluorescent Antibody Technique | 3 | 2011 | 227 | 0.110 |
Why?
| | Mice, Nude | 1 | 2009 | 211 | 0.110 |
Why?
| | Transplantation, Heterologous | 1 | 2009 | 191 | 0.110 |
Why?
| | Immunosuppressive Agents | 1 | 2009 | 200 | 0.100 |
Why?
| | Bacterial Proteins | 1 | 2012 | 566 | 0.100 |
Why?
| | Drosophila melanogaster | 3 | 2011 | 399 | 0.100 |
Why?
| | Fibroblasts | 1 | 2009 | 292 | 0.100 |
Why?
| | Fetal Viability | 1 | 2006 | 1 | 0.100 |
Why?
| | Epithelial Cells | 1 | 2009 | 242 | 0.100 |
Why?
| | Mice, Inbred BALB C | 1 | 2009 | 811 | 0.100 |
Why?
| | Fetal Development | 1 | 2006 | 12 | 0.100 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2006 | 42 | 0.090 |
Why?
| | Cell Enlargement | 1 | 2006 | 9 | 0.090 |
Why?
| | Embryo, Mammalian | 1 | 2006 | 125 | 0.090 |
Why?
| | Precipitin Tests | 2 | 2004 | 97 | 0.090 |
Why?
| | Ribosomes | 1 | 2006 | 93 | 0.090 |
Why?
| | Down-Regulation | 1 | 2006 | 256 | 0.090 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 180 | 0.080 |
Why?
| | Genes, Tumor Suppressor | 1 | 2005 | 75 | 0.080 |
Why?
| | Immunoblotting | 2 | 2004 | 191 | 0.080 |
Why?
| | Blotting, Western | 2 | 2011 | 548 | 0.080 |
Why?
| | Cell Cycle | 3 | 2013 | 341 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2007 | 319 | 0.080 |
Why?
| | Transcription, Genetic | 2 | 2015 | 795 | 0.080 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 1521 | 0.080 |
Why?
| | Phosphoproteins | 1 | 2004 | 185 | 0.070 |
Why?
| | Molecular Sequence Data | 3 | 2004 | 2081 | 0.070 |
Why?
| | Actomyosin | 1 | 2002 | 18 | 0.070 |
Why?
| | RNA | 1 | 2004 | 285 | 0.070 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2002 | 32 | 0.070 |
Why?
| | Yeasts | 1 | 2002 | 44 | 0.070 |
Why?
| | Eukaryotic Cells | 1 | 2002 | 53 | 0.070 |
Why?
| | Microtubule-Associated Proteins | 1 | 2002 | 117 | 0.070 |
Why?
| | Phosphotransferases | 1 | 2001 | 15 | 0.070 |
Why?
| | Catalysis | 1 | 2001 | 113 | 0.060 |
Why?
| | Microtubules | 1 | 2002 | 226 | 0.060 |
Why?
| | Catalytic Domain | 1 | 2001 | 87 | 0.060 |
Why?
| | Plasmids | 1 | 2001 | 245 | 0.060 |
Why?
| | Homeostasis | 2 | 2012 | 225 | 0.060 |
Why?
| | Structure-Activity Relationship | 1 | 2001 | 267 | 0.060 |
Why?
| | Temperature | 1 | 2001 | 253 | 0.060 |
Why?
| | Alleles | 1 | 2001 | 310 | 0.060 |
Why?
| | Mutagenesis | 1 | 2000 | 116 | 0.060 |
Why?
| | Tubulin | 1 | 2000 | 75 | 0.060 |
Why?
| | Microscopy, Fluorescence | 1 | 2001 | 362 | 0.060 |
Why?
| | Recombinant Fusion Proteins | 1 | 2001 | 480 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2000 | 349 | 0.060 |
Why?
| | Cloning, Molecular | 1 | 2000 | 370 | 0.060 |
Why?
| | Protein Biosynthesis | 1 | 2001 | 268 | 0.060 |
Why?
| | DNA-Binding Proteins | 1 | 2004 | 1018 | 0.050 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2015 | 12 | 0.040 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 20 | 0.040 |
Why?
| | RNA Polymerase II | 1 | 2015 | 63 | 0.040 |
Why?
| | Enzyme Activation | 2 | 2005 | 331 | 0.040 |
Why?
| | Time Factors | 1 | 2000 | 2592 | 0.040 |
Why?
| | Sequence Alignment | 2 | 2004 | 274 | 0.040 |
Why?
| | Adipose Tissue | 1 | 2015 | 221 | 0.040 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 2012 | 8 | 0.040 |
Why?
| | Gene Expression Regulation, Leukemic | 1 | 2012 | 34 | 0.040 |
Why?
| | Gluconeogenesis | 1 | 2012 | 12 | 0.040 |
Why?
| | Muscle Neoplasms | 1 | 2011 | 3 | 0.030 |
Why?
| | Glucose Clamp Technique | 1 | 2012 | 68 | 0.030 |
Why?
| | Aurothioglucose | 1 | 2011 | 2 | 0.030 |
Why?
| | Hepatocyte Nuclear Factor 3-beta | 1 | 2011 | 4 | 0.030 |
Why?
| | Phosphatidate Phosphatase | 1 | 2011 | 1 | 0.030 |
Why?
| | ras Proteins | 1 | 2011 | 57 | 0.030 |
Why?
| | Survival Analysis | 1 | 2012 | 372 | 0.030 |
Why?
| | Muscle Development | 1 | 2011 | 43 | 0.030 |
Why?
| | Chromatin | 1 | 2015 | 389 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2011 | 54 | 0.030 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2012 | 146 | 0.030 |
Why?
| | Hematopoietic Stem Cells | 1 | 2012 | 211 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2011 | 76 | 0.030 |
Why?
| | Antirheumatic Agents | 1 | 2011 | 114 | 0.030 |
Why?
| | Triglycerides | 1 | 2011 | 212 | 0.030 |
Why?
| | Cytokines | 1 | 2013 | 716 | 0.030 |
Why?
| | Genome | 1 | 2011 | 139 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2011 | 305 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2011 | 771 | 0.030 |
Why?
| | Genomics | 1 | 2011 | 148 | 0.030 |
Why?
| | Rats | 1 | 2011 | 1783 | 0.030 |
Why?
| | Models, Genetic | 1 | 2006 | 226 | 0.020 |
Why?
| | Serine | 1 | 2005 | 58 | 0.020 |
Why?
| | Gene Components | 1 | 2004 | 6 | 0.020 |
Why?
| | Immunoprecipitation | 1 | 2005 | 125 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2006 | 698 | 0.020 |
Why?
| | Equipment Failure Analysis | 1 | 2004 | 65 | 0.020 |
Why?
| | Software | 1 | 2006 | 237 | 0.020 |
Why?
| | Genetic Testing | 1 | 2004 | 67 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2006 | 435 | 0.020 |
Why?
| | Equipment Design | 1 | 2004 | 232 | 0.020 |
Why?
| | Conserved Sequence | 1 | 2004 | 172 | 0.020 |
Why?
| | Protein Kinase C | 1 | 2004 | 103 | 0.020 |
Why?
| | Macromolecular Substances | 1 | 2004 | 156 | 0.020 |
Why?
| | DNA Primers | 1 | 2004 | 307 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2006 | 986 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 294 | 0.020 |
Why?
| | Actins | 1 | 2004 | 213 | 0.020 |
Why?
| | Hela Cells | 1 | 2004 | 485 | 0.020 |
Why?
| | Transfection | 1 | 2004 | 640 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2005 | 861 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2004 | 588 | 0.010 |
Why?
|
|
Guertin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|